Drug intelligence / Profile preview

Arthrys 3D

Development stage: Preclinical
Lead developer: Tiss'You
Administration: Intraarticular

Overview

Arthrys 3D is a medical device developed by Tiss' You, designed as a next-generation viscosupplementation therapy for joint health management. Administered via intra-articular injection, it is intended to restore the rheological properties of synovial fluid, providing essential lubrication and mechanical cushioning within the joint space. This treatment approach is primarily aimed at managing symptoms of degenerative joint conditions, such as osteoarthritis, by reducing friction and improving joint mobility. As a '3D' concept, it likely utilizes a specific structural or cross-linking formulation to enhance the longevity and efficacy of the viscosupplement within the articular environment.

Brand names: Arthrys 3DArthrys3DArthrys-3D

Beyond the preview

Go deeper on Arthrys 3D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arthrys 3D.

Explore the full profile